© 2023 The American Journal of Medicine Blog. All Rights Reserved.
Inhaled corticosteroids
What's New from AJM
Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression
In patients with respiratory disease, inhaled corticosteroid use is associated with modest increases in the risks of diabetes onset and diabetes progression. The risks are more pronounced at the higher doses currently prescribed in the treatment of chronic obstructive pulmonary disease.Abstract BackgroundSystemic corticosteroids are known to increase diabetes risk, but the effects of high-dose inhaled corticosteroids are unknown....